Xiaoqing Han,Alan Whitehead,Subharekha Raghavan,Timothy A. Cernak,Spencer Dreher,Jonathan Groeper,Jian Guo,Yong Zhang
申请号：
US15103148
公开号：
US09783552B2
申请日:
2014.12.05
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A compound of Formula I or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (“cGMP”) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula I or a pharmaceutically acceptable salt thereof.
